Aelis Farma: Ordinary General Meeting of June 28, 2022: Avai

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »),

Related Keywords

United States , France , French , Nicolas Merigeau , Vincenzo Piazza , Inserm Magendie Neurocentre , Daelis Farma , Albert Marquet , Inserm Transfert Initiative , Centre Broca Nouvelle Aquitaine , Neurology Of The French Academy Sciences , Regulatory News , Ordinary General Meeting , General Meeting , Investors General , Commercial Code , Signaling Specific , Pier Vincenzo Piazza , Grand Prix , French Academy , Nouvelle Aquitaine Region , Euronext Paris , Marine De Fages , Saelis , Sarma , Rdinary , Eneral , Meeting , Pune , 022 , Availability , Preparatory , Documents , Participation , Voting , Procedures ,